RONAPREVE

Licence status
Authorised: 11/12/2021
Active substances
casirivimab, imdevimab
Dosage Form
Solution for injection/infusion
Licence number
EU/1/21/1601/001
Licence holder
Roche Registration GmbH

Product documents

Licence information

ATC code
J06BD07 casirivimab and imdevimab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
11/12/2021